Our services have evolved over time to meet the increasing need for health economic, evidence based solutions, clinical data management, regulatory and risk management; our vast experience across a wide range of disease areas is second to none.
We provide services at every stage of the product lifecycle including:

Pre-launch evaluations of disease burden and outcome evidence

Registration or global trial submission

Phase I-IV clinical trial management

Phase II/III patient reported outcomes and economic study design, conduct, analysis, and report

Development of comprehensive health economic models

Input into pricing decisions and develop strategy to meet market access requirements

Preparation of HTA and health outcomes value dossiers according to country requirement

Development of post-launch access strategy and communication tools

Develop regulatory and risk management strategic plan